The South African Medical Research Council (SAMRC) has granted a five-year extension to the SAMRC/NWU Extramural Unit (EMU) for Hypertension and Cardiovascular Disease, effective from the beginning of April 2025. This decision follows a successful review process and highlights the crucial role of the unit in addressing the burden of cardiovascular diseases (CVDs) in South Africa.

The review panel highlighted the valuable contributions of the EMU to research on hypertension and cardiovascular health, recognising its work in advancing clinical, pathophysiological and epidemiological knowledge. The SAMRC/NWU EMU focuses on understanding the development of CVD, from early detection in children to more advanced stages in the elderly, exploring genetic and lifestyle factors unique to South African communities. Its research aims to reduce CVD prevalence through early intervention, improved public health initiatives and evidence-based strategies tailored to the South African context.

In addition to its research contributions, the EMU has been committed to community engagement through initiatives such as May Measurement Month, a global hypertension awareness campaign and educational programmes that promote healthy lifestyles to prevent CVD. The EMU also works closely with schools, clinics and workplaces, sharing information on how individuals can reduce their risk of developing cardiovascular diseases.

Prof Marlien Pieters, the director of the SAMRC/NWU EMU, expressed her enthusiasm about the extension, sharing that it is a significant recognition of their team’s ongoing dedication to improving the health outcomes of South Africans. It enables them to continue critical work in understanding and preventing CVDs, particularly in the context of our diverse population.

As South Africa faces a growing challenge with non-communicable diseases (NCDs), including CVDs, the SAMRC/NWU EMU is well positioned to contribute to the country’s health goals. With support from both the SAMRC and the NWU, the unit continues to play a pivotal role in shaping policies, developing treatment guidelines and delivering public health strategies that aim to reduce CVD prevalence and improve the quality of life of South Africans.

Prof Marlien Pieters